Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Henry

Showing results (1151-1160 of 1,277) with videos related to

Pageof 128
Sort By:
The Canadian Journal of Cardiology|January 16, 2026
Defining Metrics and the Framework for the Invasive Assessment of Patients with Presumed Coronary Microvascular and Vasomotor DysfunctionLaurie-Anne Boivin-Proulx, Erick Schampaert, Kevin Bainey, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention PopulationSorin J Brener, Ajay J Kirtane, Michael J Rinaldi, et al.
Contemporary Clinical Trials|July 20, 2011
Cell therapy and satellite centers: the Cardiovascular Cell Therapy Research Network experienceLemuel A Moyé, Timothy D Henry, Kenneth W Baran, et al.
Circulation Research|July 9, 2011
Intramyocardial, autologous CD34+ cell therapy for refractory anginaDouglas W Losordo, Timothy D Henry, Charles Davidson, et al.
Journal of Animal Science|December 8, 2015
Effects of administration of prostaglandin F at initiation of the seven-day CO-Synch+controlled internal drug release ovulation synchronization protocol for suckled beef cows and replacement beef heifersV R G Mercadante, L E Kozicki, F M Ciriaco, et al.
American Heart Journal|March 11, 2025
Rationale and design of the ILIAS ANOCA clinical trial: A blinded-arm controlled trial for routine ad-hoc coronary function testingCoen K M Boerhout, Hanae F Namba, Tommy Liu, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registryUsman Baber, Roxana Mehran, Ajay J Kirtane, et al.
Journal of Hepatology|September 9, 2014
Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trialCurtis K Argo, James T Patrie, Carolin Lackner, et al.
JACC. Cardiovascular Interventions|January 31, 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESKatherine H Chau, Ajay J Kirtane, Rachel M Easterwood, et al.
American Heart Journal|June 5, 2017
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS studyUsman Baber, Samantha Sartori, Melissa Aquino, et al.
Pageof 128

Showing results (1151-1160 of 1,277) with videos related to

Sort By:
Pageof 128
The Canadian Journal of Cardiology|January 16, 2026
Defining Metrics and the Framework for the Invasive Assessment of Patients with Presumed Coronary Microvascular and Vasomotor DysfunctionLaurie-Anne Boivin-Proulx, Erick Schampaert, Kevin Bainey, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention PopulationSorin J Brener, Ajay J Kirtane, Michael J Rinaldi, et al.
Contemporary Clinical Trials|July 20, 2011
Cell therapy and satellite centers: the Cardiovascular Cell Therapy Research Network experienceLemuel A Moyé, Timothy D Henry, Kenneth W Baran, et al.
Circulation Research|July 9, 2011
Intramyocardial, autologous CD34+ cell therapy for refractory anginaDouglas W Losordo, Timothy D Henry, Charles Davidson, et al.
Journal of Animal Science|December 8, 2015
Effects of administration of prostaglandin F at initiation of the seven-day CO-Synch+controlled internal drug release ovulation synchronization protocol for suckled beef cows and replacement beef heifersV R G Mercadante, L E Kozicki, F M Ciriaco, et al.
American Heart Journal|March 11, 2025
Rationale and design of the ILIAS ANOCA clinical trial: A blinded-arm controlled trial for routine ad-hoc coronary function testingCoen K M Boerhout, Hanae F Namba, Tommy Liu, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registryUsman Baber, Roxana Mehran, Ajay J Kirtane, et al.
Journal of Hepatology|September 9, 2014
Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trialCurtis K Argo, James T Patrie, Carolin Lackner, et al.
JACC. Cardiovascular Interventions|January 31, 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESKatherine H Chau, Ajay J Kirtane, Rachel M Easterwood, et al.
American Heart Journal|June 5, 2017
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS studyUsman Baber, Samantha Sartori, Melissa Aquino, et al.
Pageof 128